S. Crowe

640 citations

16 papers · 461 indexed · 1 hit paper · h-index 6

Impact in

Endocrinology, Diabetes and Metabolism top 5%
- Diabetes Treatment and Management
- Diabetes Management and Research
Cardiology and Cardiovascular Medicine
- Cardiovascular Function and Risk Factors
- Heart Failure Treatment and Management

Papers in ⓘ

Endocrinology, Diabetes and Metabolism 6
- Diabetes Treatment and Management 6
- Diabetes Management and Research 3
Internal Medicine 1

Co-authors: I. Tikkanen (4 shared papers)Uli C. Broedl (4 shared papers)Robert Ćhilton (3 shared papers)Odd Erik Johansen (3 shared papers)Christopher P. Cannon (2 shared papers)Hans J. Woerle (2 shared papers)Stefano Del Prato (2 shared papers)H.J. Woerle (3 shared papers)
Journals: Journal of Clinical Oncology (3 papers)Journal of Hypertension (3 papers)The Astrophysical Journal (3 papers)Diabetes Obesity and Metabolism (2 papers)Nutrition Metabolism and Cardiovascular Diseases (1 paper)
Partner nations: Germany United States Italy

In The Last Decade

S. Crowe

14 papers receiving 450 citations

Hit Papers

align trajectories log scale

Effects of empagliflozin on blood pressure and markers of arterial stiffness and vascular resistance in patients with type 2 diabetes 2015 · 372 citations

Peers

Countries citing papers authored by S. Crowe

Since Specialization

Citations

This map shows the geographic impact of S. Crowe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Crowe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Crowe more than expected).

Fields of papers citing papers by S. Crowe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Crowe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Crowe. The network helps show where S. Crowe may publish in the future.

Co-authors

The 25 scholars most cited alongside S. Crowe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with S. Crowe Line = papers co-authored together S. Crowe links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work
1	Effects of empagliflozin on blood pressure and markers of arterial stiffness and vascular resistance in patients with type 2 diabetes Diabetes Obesity and Metabolism ·Robert Ćhilton, I. Tikkanen, Christopher P. Cannon, S. Crowe, Hans J. Woerle, Uli C. Broedl, Odd Erik Johansen Hit paper breakdown →	2015	372
2	Linagliptin treatment in subjects with type 2 diabetes with and without mild‐to‐moderate renal impairment Diabetes Obesity and Metabolism ·Per‐Henrik Groop, Stefano Del Prato, Marja‐Riitta Taskinen, David R. Owens, Yan Gong, S. Crowe, S. Patel, Maximilian von Eynatten, H.J. Woerle	2014	41
3	Combination of trastuzumab and letrozole after resistance to sequential trastuzumab and aromatase inhibitor monotherapies in patients with estrogen receptor-positive, HER-2-positive advanced breast cancer: a proof-of-concept trial (SAKK 23/03) Endocrine Related Cancer ·Dieter Koeberle, Thomas Ruhstaller, Jost Langhorst, Olivia Pagani, Khalil Zaman, Roger von Moos, C. Oehlschlegel, S. Crowe, Christiane Pilop, Beat Thuerlimann	2011	13
4	Potential relevance of changes in haematocrit to changes in lipid parameters with empagliflozin in patients with type 2 diabetes Diabetologie und Stoffwechsel ·SS Lund, N Sattar, Afshin Salsali, S. Crowe, UC Broedl, HN Ginsberg	2016	8
5	4B.01 Journal of Hypertension ·David Cherney, M. E. Cooper, I. Tikkanen, S. Crowe, Odd Erik Johansen, Søren S. Lund, H.J. Woerle, Uli C. Broedl, Thomas Hach	2015	7
6	Efficacy and safety of linagliptin according to patient baseline characteristics: A pooled analysis of three phase 3 trials Nutrition Metabolism and Cardiovascular Diseases ·Stefano Del Prato, S. Patel, S. Crowe, Maximilian von Eynatten	2016	6
7	4B.02 Journal of Hypertension ·Robert Ćhilton, I. Tikkanen, Christopher P. Cannon, S. Crowe, Thomas Hach, Hans J. Woerle, Uli C. Broedl, Odd Erik Johansen	2015	4
8	4B.03 Journal of Hypertension ·Robert Ćhilton, I. Tikkanen, S. Crowe, OE Johansen, Uli C. Broedl, H.J. Woerle, Thomas Hach	2015	3
9	Bevacizumab (B) and erlotinib (E) as first-line therapy in metastatic nonsquamous non-small cell lung cancer (NSCLC) followed by platinum-based chemotherapy (CT) at disease progression (PD): A multicenter phase II trial, SAKK 19/05. Journal of Clinical Oncology ·Francesco Zappa, C. Droege, Daniel Betticher, Roger von Moos, Martin Brutsche, Florent Baty, Lukas Bubendorf, Adrian F. Ochsenbein, Elisabeth Oppliger Leibundgut, Oliver Gautschi, Patrizia Froesch, R. Stahel, Daniel Rauch, Peter Schmid, Michael Mayer, S. Crowe, Peter Brauchli, Karin Ribi, Miklos Pless	2011	2
10	The JWST-NIRCam View of Sagittarius C. I. Massive Star Formation and Protostellar Outflows The Astrophysical Journal ·S. Crowe, R. Fedriani, Jonathan C. Tan, Alva V. I. Kinman, Yichen Zhang, Morten Andersen, Lucía Bravo Ferres, F. Nogueras-Lara, R. Schöedel, John Bally, Adam Ginsburg, Yu Cheng, Yao-Lun Yang, Sarah Kendrew, Chi-Yan Law, Joseph J. Armstrong, Zhi‐Yun Li	2025	1
11	Metformin in Chemotherapy-Naïve Castration Resistant Prostate Cancer (CRPC): A Multicenter Phase II Trial (SAKK 08/09) Annals of Oncology ·Christian Rothermundt, Richard Cathomas, Arnoud J. Templeton, Ralph C. Winterhalder, Raeto T. Strebel, Daniela Baertschi, Michaël Pollak, L. Lui, S. Crowe, Silke Gillessen	2012	1
12	Whole blood transcriptomics analysis of 24h responses to bevacizumab/erlotinib in nonsquamous non-small cell lung cancer: A multicenter phase II trial SAKK19/05. Journal of Clinical Oncology ·Florent Baty, M. Frueh, S. Crowe, K. J. Na, C. Droege, Daniel Betticher, Richard Cathomas, Francesco Zappa, Miklos Pless, Martin Brutsche	2011	1
13	Exonic expression variations of EGFR and KRAS in small bronchoscopic biopsies from patients with advanced non-small cell lung cancer treated by combined bevacizumab/erlotinib therapy followed by platinum-based chemotherapy at disease progression: A multicenter phase II trial SAKK19/05. Journal of Clinical Oncology ·Martin Brutsche, M. Frueh, S. Crowe, K. J. Na, C. Droege, Daniel Betticher, Roger von Moos, Francesco Zappa, Miklos Pless, Lukas Bubendorf, Florent Baty	2011	1
14	Clinically Significant Bleeding in Incurable Cancer Patients: Effectiveness of Hemostatic Radiation Therapy International Journal of Radiation OncologyBiologyPhysics ·Nikola Čihorić, S. Crowe, Steffen Eychmüller, Daniel M. Aebersold, Pirus Ghadjar	2012	1
15	The JWST-NIRCam View of Sagittarius C. II. Evidence for Magnetically Dominated H ii Regions in the Central Molecular Zone The Astrophysical Journal ·John Bally, S. Crowe, R. Fedriani, Adam Ginsburg, R. Schöedel, Morten Andersen, Jonathan C. Tan, Zhi‐Yun Li, F. Nogueras-Lara, Yu Cheng, Chi-Yan Law, Q. Daniel Wang, Yichen Zhang, Suinan Zhang	2025	0
16	The SOFIA Massive (SOMA) Star Formation Survey. V. Clustered Protostars The Astrophysical Journal ·Zoie Telkamp, R. Fedriani, Jonathan C. Tan, Chi-Yan Law, Yichen Zhang, Adele Plunkett, S. Crowe, Yao-Lun Yang, James M. De Buizer, M. T. Beltrán, M. Bonfand, Ryan D. Boyden, Giuliana Cosentino, Prasanta Gorai, Mengyao Liu, Viviana Rosero, Kotomi Taniguchi, Kei Tanaka, Tatiana M. Rodríguez	2025	0

About S. Crowe

S. Crowe is a scholar working on Endocrinology, Diabetes and Metabolism, Internal Medicine, Astronomy and Astrophysics, Cancer Research and Hepatology, having authored 16 papers that have together received 461 indexed citations. Recurring topics across this work include Diabetes Treatment and Management (6 papers), Diabetes Management and Research (3 papers), Metabolism, Diabetes, and Cancer (3 papers), Stellar, planetary, and galactic studies (3 papers), Astrophysics and Star Formation Studies (3 papers), Lung Cancer Treatments and Mutations (3 papers), Cancer Genomics and Diagnostics (2 papers) and Astrophysical Phenomena and Observations (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (396 citations), Cardiology and Cardiovascular Medicine (123 citations), Nephrology (35 citations), Surgery (159 citations) and Pharmacology (58 citations). S. Crowe has collaborated with scholars based in Germany, United States and Italy. Frequent co-authors include I. Tikkanen, Uli C. Broedl, Robert Ćhilton, Odd Erik Johansen, Christopher P. Cannon, Hans J. Woerle, Stefano Del Prato, H.J. Woerle, S. Patel and Maximilian von Eynatten. Their work appears in journals such as Journal of Clinical Oncology, Journal of Hypertension, The Astrophysical Journal, Diabetes Obesity and Metabolism and Nutrition Metabolism and Cardiovascular Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact